Ignite Creation Date:
2025-12-24 @ 10:50 PM
Ignite Modification Date:
2025-12-28 @ 7:34 PM
Study NCT ID:
NCT00006269
Status:
TERMINATED
Last Update Posted:
2012-05-25
First Post:
2000-09-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer
Sponsor:
Novartis
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1999-12
Start Date Type:
None
Primary Completion Date:
1999-12
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2000-09-11
First Submit QC Date:
None
Study First Post Date:
2004-05-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-05-24
Last Update Post Date:
2012-05-25
Last Update Post Date Type:
ESTIMATED